-transparent.png){kind=logo}
A case of severe acute hepatitis caused by cyproterone acetate in a 71 year old man with prostatic carcinoma is reported with a review of the literature on hepatic reactions to this drug. The association between the use of cyproterone acetate and liver abnormalities is poorly documented. This is the fourth published report of adverse hepatic reaction to cyproterone acetate and it substantiates other evidence that cyproterone acetate is potentially hepatotoxic. Monitoring of liver function tests should be mandatory in patients receiving high doses of cyproterone acetate; the drug should be withdrawn immediately if abnormal liver function tests are found.
Related Publications
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
January 1994,
Therapie,
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
January 1991,
Gastroenterologie clinique et biologique,
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
October 1996,
Australian and New Zealand journal of medicine,
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
January 1996,
Gastroenterologie clinique et biologique,
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
September 2001,
The Annals of pharmacotherapy,
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
January 2013,
Annals of hepatology,
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
August 1998,
Allergy,
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
January 1992,
European journal of cancer (Oxford, England : 1990),
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
December 1981,
Drug and therapeutics bulletin,
J C Blake, and
A M Sawyerr, and
J S Dooley, and
P J Scheuer, and
N McIntyre
March 1994,
Israel journal of medical sciences,
